Search Thermo Fisher Scientific
Bethyl Laboratories
图: 1 / 1
Daratumumab (Darzalex) is a human monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of multiple myeloma. Daratumumab binds to CD38 on multiple myeloma cells and induces cells to apoptose via antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Darzalex; HuMax-CD38